Correlation Between Amicus Therapeutics and Evolus
Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amicus Therapeutics and Evolus Inc, you can compare the effects of market volatilities on Amicus Therapeutics and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Evolus.
Diversification Opportunities for Amicus Therapeutics and Evolus
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Amicus and Evolus is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Evolus go up and down completely randomly.
Pair Corralation between Amicus Therapeutics and Evolus
Given the investment horizon of 90 days Amicus Therapeutics is expected to under-perform the Evolus. But the stock apears to be less risky and, when comparing its historical volatility, Amicus Therapeutics is 1.29 times less risky than Evolus. The stock trades about 0.0 of its potential returns per unit of risk. The Evolus Inc is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 1,300 in Evolus Inc on September 3, 2024 and sell it today you would earn a total of 69.00 from holding Evolus Inc or generate 5.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Amicus Therapeutics vs. Evolus Inc
Performance |
| Timeline |
| Amicus Therapeutics |
| Evolus Inc |
Amicus Therapeutics and Evolus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Amicus Therapeutics and Evolus
The main advantage of trading using opposite Amicus Therapeutics and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.| Amicus Therapeutics vs. Incyte | Amicus Therapeutics vs. Denali Therapeutics | Amicus Therapeutics vs. argenx NV ADR | Amicus Therapeutics vs. Harmony Biosciences Holdings |
| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |